Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

synchrony pharma ltd - doxapram hydrochloride - solution for injection - 20mg/1ml

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

taro pharmaceuticals (ireland) limited - doxapram hydrochloride - solution for injection - 20 mg/ml

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

taro pharmaceuticals (ireland) limited - doxapram hydrochloride - solution for injection - 20 mg/ml

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - escitalopram oxalate, quantity: 25.551 mg/ml (equivalent: escitalopram, qty 20 mg/ml) - oral liquid, solution - excipient ingredients: sodium hydroxide; ethanol; purified water; propyl gallate; citric acid - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - escitalopram oxalate, quantity: 25.54 mg (equivalent: escitalopram, qty 20 mg) - tablet, film coated - excipient ingredients: purified talc; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; purified water; macrogol 400 - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - escitalopram oxalate, quantity: 12.77 mg (equivalent: escitalopram, qty 10 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; purified talc; titanium dioxide; hypromellose; purified water; macrogol 400 - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - doxapram hydrochloride monohydrate - parenteral liquid/solution/suspension - doxapram hydrochloride monohydrate stimulant-brain active 20.0 mg/ml - respiratory system - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - respiratory stimulant | anaesthetic awakening | respiratory stimulant

Nova Zelândia - inglês - Ministry for Primary Industries

elanco new zealand - doxapram hydrochloride - doxapram hydrochloride 20 g/litre - cns stimulant

Estados Unidos - inglês - NLM (National Library of Medicine)

physicians total care, inc. - escitalopram oxalate (unii: 5u85dbw7lo) (escitalopram - unii:4o4s742any) - escitalopram oxalate 5 mg -   lexapro (escitalopram) is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [see clinical studies (14.1) ]. a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. lexapro is indicated for the acute treatment of generalized anxiety disorder (gad) in adults [see clinical studies (14.2) ]. generalized anxiety disorder (dsm-iv) is characterized by excessive anxiety and worry (apprehensive expectation) that is persistent for at

Estados Unidos - inglês - NLM (National Library of Medicine)

direct rx - escitalopram oxalate (unii: 5u85dbw7lo) (escitalopram - unii:4o4s742any) - escitalopram 10 mg - 1.1 major depressive disorder escitalopram tablets usp are indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [see clinical studies (14.1)]. a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. 1.2 generalized anxiety disorder escitalopram tablets are indicated for the acute treatment of generalized anxiety disorder (gad) in adults [see clinical studies (14.2)]. generalized anxiety disorder (dsm-iv) is characterized by excessive anxiety